PASITHEA THERAPEUTICS CORP. Derivative Liability
PASITHEA THERAPEUTICS CORP. (KTTA) had Derivative Liability of $69.52 thousand as of 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2023-08-11
- 2023-06-30: Derivative Liability $69.52K.
- 2023-03-31: Derivative Liability $176.00K.
- 2022-12-31: Derivative Liability $132.00K.
- 2022-09-30: Derivative Liability $581.12K.
| Period end | Derivative Liability |
|---|---|
| 2023-06-30 | $69.52K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $176.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $132.00K 10-Q · filed 2023-08-11 |
| 2022-09-30 | $581.12K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $245.80K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $667.50K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $1.45M 10-Q · filed 2022-11-14 |
| 2021-09-30 | $4.04M 10-Q · filed 2021-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |